Genex ApS: Financial statements 2023
CVR: 42881112
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Genex ApS (CVR 42881112) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -5,987 and a net result of DKK -5,971 compared with DKK -9,372 the year before. Equity in the 2023 report amounted to DKK 24,647. The solvency ratio was 89.2%.
- Gross Profit
- DKK -5,987
- Profit/Loss
- DKK -5,971
- Equity
- DKK 24,647
- Total Assets
- DKK 27,620
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -6 t. | -6 t. | 25 t. | - |
| 2022 | - | -9 t. | -9 t. | 31 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Genex ApS has published its annual report for 2022. Gross profit came to DKK -9,372, and the net result was DKK -9,372.
About Genex ApS
Genex ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2021. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The management consists of Lone Majbritt Christiansen. The company is owned by Lone Majbritt Christiansen. In 2025, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,434 the year before. Equity in the 2025 report amounted to DKK 21,713.